Mereo BioPharma (MREO) Change in Accured Expenses (2023 - 2026)
Mereo BioPharma (MREO) reported Change in Accured Expenses of $229000.0 for Q1 2026, up 116.47% year-over-year from $105786.0 in Q1 2025, and up 110.13% quarter-over-quarter from -$2.3 million in Q4 2025.
Mereo BioPharma (MREO) Change in Accured Expenses (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Change in Accured Expenses data on file, last reported at $229000.0 in Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at $229000.0, up 116.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$775000.0 (down 317.09% YoY), and the FY2025 annual result was -$2.4 million, down 100.84% from the prior year.
- Change in Accured Expenses advanced to $229000.0 in Q1 2026 per MREO's latest filing, from -$2.3 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $4.2 million in Q2 2023 and troughed at -$3.1 million in Q1 2023.
- A 4-year average of -$312846.2 and a median of -$706000.0 in 2024 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses sank 442.47% in 2024, then soared 116.47% in 2026.
- A 4-year view of Change in Accured Expenses shows it stood at -$1.7 million in 2023, then soared by 58.79% to -$706000.0 in 2024, then slumped by 220.25% to -$2.3 million in 2025, then jumped by 110.13% to $229000.0 in 2026.
- Business Quant data shows MREO's Change in Accured Expenses at $229000.0 in Q1 2026, -$2.3 million in Q4 2025, and -$673000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 931,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 70.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | 229,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 229,000.00 |
| Mar 31, 2026 | 229,000.00 |
| Dec 31, 2025 | -2.26 Mn |
| Dec 31, 2025 | -2.26 Mn |
| Sep 30, 2025 | -673,000.00 |
| Sep 30, 2025 | -673,000.00 |
| Jun 30, 2025 | 1.93 Mn |
| Jun 30, 2025 | 1.93 Mn |
| Mar 31, 2025 | -1.39 Mn |
| Mar 31, 2025 | -1.39 Mn |
| Dec 31, 2024 | -706,000.00 |
| Dec 31, 2024 | -706,000.00 |
| Sep 30, 2024 | -792,000.00 |
| Sep 30, 2024 | -792,000.00 |
| Jun 30, 2024 | 3.25 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | -2.94 Mn |
| Mar 31, 2024 | -2.94 Mn |
| Dec 31, 2023 | -1.71 Mn |
| Dec 31, 2023 | -1.71 Mn |